ID: ALA5220036

Max Phase: Preclinical

Molecular Formula: C17H14N4O2

Molecular Weight: 306.33

Associated Items:

Representations

Canonical SMILES:  NC(=O)c1cc2c(N)ncnc2cc1-c1ccc2c(c1)CCO2

Standard InChI:  InChI=1S/C17H14N4O2/c18-16-13-6-12(17(19)22)11(7-14(13)20-8-21-16)9-1-2-15-10(5-9)3-4-23-15/h1-2,5-8H,3-4H2,(H2,19,22)(H2,18,20,21)

Standard InChI Key:  YCOOAERXXWCTKI-UHFFFAOYSA-N

Associated Targets(Human)

PI4-kinase type II 62 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

PI4-kinase alpha subunit 184 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

PI4-kinase beta subunit 1593 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Topical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 306.33Molecular Weight (Monoisotopic): 306.1117AlogP: 1.91#Rotatable Bonds: 2
Polar Surface Area: 104.12Molecular Species: NEUTRALHBA: 5HBD: 2
#RO5 Violations: 0HBA (Lipinski): 6HBD (Lipinski): 4#RO5 Violations (Lipinski): 0
CX Acidic pKa: CX Basic pKa: 4.45CX LogP: 1.57CX LogD: 1.57
Aromatic Rings: 3Heavy Atoms: 23QED Weighted: 0.75Np Likeness Score: -0.47

References

1. Misehe M, Klima M, Matoušová M, Chalupská D, Dejmek M, Šála M, Mertlíková-Kaiserová H, Boura E, Nencka R..  (2022)  Structure-based design and modular synthesis of novel PI4K class II inhibitors bearing a 4-aminoquinazoline scaffold.,  76  [PMID:36184029] [10.1016/j.bmcl.2022.129010]

Source